Xtant Medical Holdings Inc (XTNT) Stock Analysis

Xtant Medical Holdings Inc (XTNT) is a publicly traded company in the HEALTHCARE sector. It trades at $0.47, carries a market capitalization of $64.83M, a price-to-earnings ratio of 46.22. This page summarizes the public market data, fundamentals, and frequently asked questions for XTNT, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NYSE MKT

Key Metrics

Market Sentiment

Xtant Medical Holdings Inc currently has a Bullish sentiment score of 0.26.

About Xtant Medical Holdings Inc

Xtant Medical Holdings, Inc. is a leading provider of regenerative medicine products and advanced medical devices targeting orthopedic and neurological surgical applications, with a significant presence in both domestic and international markets. Headquartered in Belgrade, Montana, the company focuses on enhancing treatment modalities for complex surgical conditions through its diverse portfolio of innovative solutions. With a commitment to improving patient outcomes and supporting surgeons, ...

GNG Research Analysis

GNG Research scores Xtant Medical Holdings Inc (XTNT) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for XTNT.

Frequently Asked Questions

Does XTNT pay dividends?

Xtant Medical Holdings Inc (XTNT) does not currently pay a regular dividend.

What is XTNT's P/E ratio?

Xtant Medical Holdings Inc has a price-to-earnings (P/E) ratio of 46.22.

What is XTNT's market cap?

Xtant Medical Holdings Inc (XTNT) has a market capitalization of $64.83M with a current stock price of $0.47.